Global Pharmaceutical Glass Packaging Market 2021 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Pharmaceutical Glass Packaging Market 2021 (Includes Business Impact of COVID-19)
Global pharmaceutical glass packaging market is currently valued at US$ X.X Bn and is anticipated to reach a value of US$ X.X Bn. The global pharmaceutical glass packaging market report has been segmented on the basis of product type, drug type, and region.
Request Covid - 19 Impact
The global Pharmaceutical Glass Packaging market size was valued at USD$ 9.32 billion in 2020 and is projected to reach USD $18.74 billion by 2030, and is anticipated to expand at a CAGR of 7.57% over the forecast period from 2020 to 2030.


Pharmaceutical Glass Packaging: Overview


Pharmaceutical glass packaging refers to storage and packaging of medicines, tablets, and other related medicinal products into glass containers in order to avoid contamination of pharmaceuticals. Packaging can be defined as the procedure of providing identification, protection, presentation, and compliance for the product throughout storage and transportation process.


Growth Propelling and Limiting Factors for the Global Pharmaceutical Glass Packaging Market


Pharmaceutical packaging plays an important role in the delivery of medicines and other related products. In addition, packaging of pharmaceutical products such as medicines is a complex process, as its contamination can damage the quality and usability of the drugs. Some of the drugs are sensitive to direct contact with sunlight, air, and other environmental components. Therefore, medicinal companies adopt glass material for packaging which aids to protect from contamination. The glass material has various properties including resistant to chemicals, recyclability, transparency, and impermeability to air & moisture, which is another factor expected to support growth of the global market. Increasing consumption of generic drugs and growing access to healthcare services are some of the major factors expected to drive growth of the global market. Increasing governments initiatives to manufacture generic medicines to support the usage of these medicines against chronic diseases is a factor anticipated to propel the target market growth over the 10-year forecast period.

However, glass is fragile in nature, so lack of durability is one of the major factors hampering the target market growth. In addition, availability of alternative packaging solutions including plastic is a factor that could challenge growth of the global market to some extent.


Segment Analysis By Product Type:


Among the product type segments, the bottle segment is projected to account for significant revenue share in the global market, owing to its most common application for storing liquid medicines.

By Drug Type:

Among the drug types, the generic segment is expected to register significant growth rate, due to high demand for generic medicines among physicians.

Regional Analysis

Increasing demand for pharmaceutical products and technological advancements in packaging technologies are some factors expected to support growth of the North America pharmaceutical glass packaging market. This is a major factor responsible for the dominance of North America (NA) market in the global market. In addition, improved facilities of healthcare and increasing awareness regarding benefits associated with glass material for packaging are some other factors expected to support growth of the market in NA. The pharmaceutical glass packaging market in Asia Pacific is anticipated to register significant growth rate, due to increasing prevalence of chronic diseases. In addition, rapidly growing number of healthcare companies in countries in the APAC market is another factor anticipated to augment growth of the market in APAC. Markets in Latin America and MEA are anticipated to register moderate CAGR over the next 10 years.


Below are the active patents related to Pharmaceutical Glass Packaging Market.


Patent Number: US9758420B2

Method for manufacturing glass containers for pharmaceutical use

Abstract

The present invention relates to a method for manufacturing glass containers for pharmaceutical use. This method allows obtaining containers with a low degree of alkalinity. In some preferred embodiments the process allows the manufacture of sterile containers and substantially free of particles ready to be used by the pharmaceutical industry.

Application File Date: 2014-05-27

Application Granted Date: 2017-09-12

Current Assignee: Dalwick Continental Corp

Patent Number: US7430842B2

Protected vial, and method for manufacturing same

Abstract

For the prevention of contamination of a vial with traces of medicinal fluids, for example cytostatics and antibiotics, which may be spilt on the outside of the vial while filling, the vial is provided with a tight-fitting protective envelope, preferably made of a transparent synthetic material, as a last step in the production process. Because of this, a possible contamination which remains on the outside of the vial is encapsulated between the vial and the envelope. Hereby, a user is no longer exposed to toxic substances, because the user will not touch the vial itself, but will touch the envelope. An additional advantage of the provision of the envelope is that if breaking of the vial occurs, the envelope will keep the pieces of broken glass together and will possibly prevent the medicinal fluid from leaking away.

Application File Date: 2004-12-02

Application Granted Date: 2008-10-07

Current Assignee: Pharmachemie BV

Patent Number: US20130171456A1

Glass Articles With Low-Friction Coatings

Abstract

Low-friction coatings and glass articles with low-friction coatings are disclosed. According to one embodiment, a coated glass article may include a glass body comprising a first surface and a low-friction coating positioned on at least a portion of the first surface of the glass body. The low-friction coating may include a polymer chemical composition. The coated glass article may be thermally stable at a temperature of at least about 260° C. for 30 minutes. A light transmission through the coated glass article may be greater than or equal to about 55% of a light transmission through an uncoated glass article for wavelengths from about 400 nm to about 700 nm. The low-friction coating may have a mass loss of less than about 5% of its mass when heated from a temperature of 150° C. to 350° C. at a ramp rate of about 10° C./minute.

Application File Date: 2013-02-28

Application Granted Date: 2017-09-19

Current Assignee: Corning Inc

Global Pharmaceutical Glass Packaging Market Segmentation:

Based on product, the market is divided into:

  
Ampoules
  
Bottles
  
Vials
  
Syringes
  
Cartridges
  
Others

On the basis of drug type, the market is segmented into:

  
Generic
  
Branded
  
Biologic

By application, the industry is categorised into:

  
Oral
  
Injectable
  
Nasal
  
Others


Key Market Players included in the report:


  
Acme Vial and Glass Company
  
Agrado S.A.
  
Amposan S.A.
  
Arab Pharmaceutical Glass Co.
  
Ardagh Group S.A. (Luxembourg)
  
Beatson Clark Ltd.
  
Bormioli Rocco SpA (Italy)
  
Corning Incorporated
  
Dickinson and Company
  
DWK Life Sciences GmbH
  
Gerresheimer AG (Germany)
  
Hindusthan National Glass & Industries Limited
  
Nipro Corporation (Japan)
  
O.Berk Company
  
Owens-Illinois Inc.
  
Piramal Enterprises Ltd.
  
SCHOTT Pharmaceutical Packaging (U.S.)
  
SGD Pharma (France)
  
Shandong Medicinal Glass Co. Ltd.
  
Shandong Pharmaceutical Glass Co.Ltd.
  
Shandong Qidu Pharmaceutical Co.,Ltd. (China)
  
Stevanato Group (Ompi)
  
Stölzle-Oberglas Gmbh (Austria)
  
West Pharmaceutical Services Inc. (U.S.)


Below are the key development related to Pharmaceutical Glass Packaging Market in 2020 and 2021.


May 2021: Nipro PharmaPackaging completes Croatian glass acquisition. Japan-based packaging company Nipro PharmaPackaging has acquired Croatian glass pharmaceutical packaging manufacturer Piramida. Nipro said that the acquisition of Piramida and its yearly capacity in excess of 500 million glass containers, it is now able to cater to the market needs in Central Europe.Under the ownership of Blue Sea Capital private equity fund, Piramida enjoyed a modernisation of its facilities, welcomed eight new production lines, and witnessed a strong development of its ampoules and vials business. Moreover, production capacity as well as the revenue doubled. This led the company being ranked among the top five largest ampoule manufacturers for the pharmaceutical industry in the European market. Source

December 2020: Blackstone to acquire Piramal Glass for $1 billion. US-based private equity major Blackstone Group Inc will pay an upfront amount of $850 million to take over the management and ownership of Piramal Glass. US-based private equity major Blackstone Group Inc has inked a deal to acquire Piramal Enterprises Ltd.s (PEL) glass unit for $1 billion (around Rs 7,500 crore). The transaction comprises an upfront payment of $850 million to take over the management and ownership of Piramal Glass, whereas, the Piramal Group will get about $150 million on realising certain milestones, to be paid over the course of two years. Source

February 2021: ProMach Acquires Serpa Packaging Solutions. The acquisition of Serpa Packaging Solutions expands ProMach’s secondary packaging solutions for pharmaceutical applications and enhances its turnkey line integration capabilities. Serpa Packaging Solutions is a manufacturer of cartoning and end of line packaging systems for the pharmaceutical, medical device, nutraceutical, food, cosmetics, and personal care markets. The addition of Serpa brings automated cartoning systems into ProMach’s portfolio and significantly expands ProMach’s specialized secondary packaging machinery and line integration capabilities for the rapidly growing pharmaceutical industry. Source